|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 1.420 USD | -0.70% |
|
+0.71% | +31.48% |
Company Valuation: Allarity Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78.43 | 4.195 | 2.512 | 5.187 | 17.07 | 22.59 | - |
| Change | - | -94.65% | -40.12% | 106.5% | 229% | 32.39% | - |
| Enterprise Value (EV) | 78.43 | 4.195 | 2.512 | 5.187 | 17.07 | 22.59 | 22.59 |
| Change | - | -94.65% | -40.12% | 106.5% | 229% | 32.39% | 0% |
| P/E | - | -0.13x | -0.05x | - | -1.38x | -1.54x | -1.46x |
| PBR | - | - | - | - | 1.58x | - | - |
| PEG | - | - | 0x | - | - | -0.1x | -0.27x |
| Capitalization / Revenue | - | - | - | - | 53.3x | 904x | - |
| EV / Revenue | - | - | - | - | 0x | 904x | - |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | - | -0x | -0x | - | -0x | -1.71x | -1.61x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | - | -1,856,404 | -6,156 | - | -0.78 | -0.92 | -0.97 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 0.32 | 0.025 | - |
| EBITDA | - | - | - | - | - | - | - |
| EBIT 1 | - | -32.68 | -17.13 | - | -12.6 | -13.19 | -14 |
| Net income 1 | -26.65 | -21.05 | -20.42 | -25.15 | -11.23 | -14.86 | -16.15 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 8,714,405.712 | 246,787.064 | 330.660 | 1.170 | 1.080 | 1.420 | 1.420 |
| Nbr of stocks (in thousands) | 0.01 | 0.02 | 7.6 | 4,434 | 15,802 | 15,911 | - |
| Announcement Date | 5/17/22 | 3/13/23 | 3/8/24 | 3/31/25 | 3/30/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54x | - | - | - | 22.59M | |
| 20.25x | 7.04x | 14.2x | 1.45% | 67.98B | |
| 36.9x | 9.64x | 29.44x | 0.04% | 64.94B | |
| -77.3x | 14.92x | -71.95x | -.--% | 27.58B | |
| -15.85x | 6.12x | -7.7x | -.--% | 26.06B | |
| 29.69x | 6.35x | 16.48x | -.--% | 25.74B | |
| 27.41x | 5.13x | 17.06x | -.--% | 20.09B | |
| 49.41x | 18.23x | 36.98x | 0.31% | 17.16B | |
| 1289.22x | 37.23x | 812.54x | -.--% | 14.92B | |
| 18.23x | 5.44x | 12.69x | -.--% | 14.62B | |
| Average | 137.64x | 12.23x | 95.53x | 0.2% | 27.91B | |
| Weighted average by Cap. | 82.01x | 10.35x | 51.60x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALLR Stock
- Valuation Allarity Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
